Genetic Signatures Limited (ASX: GSS)
Health Care · Life Sciences Tools & Services · AU
AU$0.08
+6.33% today · -60.9% 1Y
Genetic Signatures Limited (ASX: GSS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $13.31M and employs 117 people.
Over the last twelve months the share price has lost 60.9%, trading between 0.05 and 0.43.
Tweenvest scores Genetic Signatures Limited across four factors: quality 43/100, value 65/100, growth 0/100. Its strongest factor is value.
GSS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.31M
- Revenue (TTM)
- $13.37M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- AU$0.43
- 52-week low
- AU$0.05
- Avg volume (3M)
- —
- Shares outstanding
- 227.14M
- Employees
- 117
- Next earnings
- —
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostics (MDx) enterprise, extending its reach across Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. The company engineers and manufactures an array of real-time Polymerase Chain Reaction (PCR)-based products, sold under the EasyScreen brand, for the identification of infectious diseases. Moreover, it offers its proprietary MDx 3Base platform technology, enabling hospitals and pathology laboratories to conduct comprehensive screenings for diverse infectious pathogens. Its offerings also encompass detection kits tailored for conditions such as gastrointestinal ailments, respiratory illnesses, sexual health concerns, antimicrobial resistance, meningitis, and tropical diseases. Founded in 2001, the firm is headquartered in Newtown, Australia.
- ISIN
- AU000000GSS4
- Founded
- 2001
- Listed since
- Mar 30, 2015
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jeevan Scientific Technology LimitedBSE: 538837 | $17.35M | Rs83.60 | -1.31% |
| Bionano Genomics, Inc.NasdaqCM: BNGO | $16.90M | $1.44 | -1.71% |
| Fusion Antibodies plcAIM: FAB | $16.56M | £0.10 | -11.11% |
| Proteomics International Laboratories LtdASX: PIQ | $14.43M | AU$0.13 | +4.17% |
| Malaysian Genomics Resource Centre BerhadKLSE: MGRC | $12.93M | RM0.35 | -2.78% |
| Welgene Biotech Co.,Ltd.TPEX: 6661 | $12.58M | NT$17.20 | +6.17% |
| Pharma-Bio Serv, Inc.OTCPK: PBSV | $10.99M | $0.48 | -4.00% |
| Memphasys LimitedASX: MEM | $10.77M | AU$0.01 | -16.67% |
Figures last refreshed Oct 11, 2026.